Royalty Pharma Plc (NASDAQ:RPRX) is one of the best affordable biotech stocks to invest in now. On September 12, TD Cowen analyst Michael Nedelcovych maintained a Buy rating on Royalty Pharma Plc (NASDAQ:RPRX), keeping the price target at $42.00. Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now? The analyst based the optimistic rating on the company’s promising outlook and strong performance, stating that it consistently surpassed key metrics and is set to meet or exceed it ...